Carcinoid & Neuroendocrine Tumors

Information on the symptoms, diagnosis, treatment and symptom management of NETs.
All About Carcinoid and Neuroendocrine Tumors
Tumors of the neuroendocrine system account for about 2% of all cancers and can be classified as either pancreatic endocrine tumors or carcinoid tumors. Carcinoid tumor most commonly arise in the gastrointestinal system (esophagus, stomach, intestines) and the lungs.

Everolimus Ups Survival in Carcinoid Syndrome

Nov 29, 2011 - For patients with low- or intermediate-grade advanced neuroendocrine tumors (carcinoids), everolimus plus octreotide long-acting repeatable (LAR) improves progression-free survival versus placebo plus octreotide LAR, according to a study published online

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More

OncoLink Cancer Treatment and Resources